Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 369,977 |
|
|||||
| News | - | ||||||
| Day High | 21.18 | Low High |
|||||
| Day Low | 20.3401 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prothena Corporation PLC | PRTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.32 | 1.56% | 20.87 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.72 | 20.3401 | 21.18 | 20.87 | 20.55 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,674 | 369,977 | $ 20.86 | $ 7,718,880 | - | 19.65 - 79.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:13:05 | 1 | $ 21.91 | USD |
Prothena Corporation PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.12B | 53.72M | - | 91.37M | -147.03M | -2.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prothena News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.56 | 21.79 | 19.65 | 20.83 | 436,831 | 0.31 | 1.51% |
| 1 Month | 24.92 | 26.36 | 19.65 | 22.55 | 520,562 | -4.05 | -16.25% |
| 3 Months | 26.92 | 31.03 | 19.65 | 25.85 | 637,337 | -6.05 | -22.47% |
| 6 Months | 37.78 | 41.545 | 19.65 | 31.82 | 777,124 | -16.91 | -44.76% |
| 1 Year | 54.01 | 79.65 | 19.65 | 42.73 | 624,912 | -33.14 | -61.36% |
| 3 Years | 23.90 | 79.749 | 19.65 | 45.27 | 527,594 | -3.03 | -12.68% |
| 5 Years | 10.86 | 79.749 | 6.44 | 37.02 | 425,991 | 10.01 | 92.17% |
Prothena Description
| Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). |
